General Partner Inc’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$702K Hold
585
0.38% 55
2026
Q1
$538K Sell
585
-25
-4% -$25.3K 0.33% 51
2025
Q4
$656K Hold
610
0.37% 51
2025
Q3
$465K Hold
610
0.26% 60
2025
Q2
$476K Hold
610
0.28% 59
2025
Q1
$504K Buy
610
+10
+2% +$8.32K 0.33% 54
2024
Q4
$463K Hold
600
0.28% 56
2024
Q3
$532K Hold
600
0.33% 55
2024
Q2
$543K Hold
600
0.35% 52
2024
Q1
$467K Buy
+600
New +$427K 0.29% 61

Other funds holding LLY

General Partner Inc's LLY Position: Q2 2026 in Review

General Partner Inc held its Eli Lilly (LLY) position steady in Q2 2026 at 585 shares worth $702K. The position accounts for 0.38% of the portfolio, ranked #55.

General Partner Inc first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • General Partner Inc held 585 shares of Eli Lilly worth $702K as of Q2 2026.
  • General Partner Inc left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.38% of General Partner Inc's portfolio in Q2 2026, its #55 holding.
  • General Partner Inc first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on General Partner Inc's 13F filing for Q2 2026, filed 6 Jul 2026.